Population pharmacokinetic-pharmacodynamic (PK-PD) modeling of CPX-351-induced thrombocytopenia

被引:0
|
作者
Cook, Sarah F. [1 ]
Wang, Qi [2 ]
Mager, Donald E. [1 ]
Van Wart, Scott A. [1 ]
机构
[1] Enhanced Pharmacodynam LLC, Buffalo, NY USA
[2] Jazz Pharmaceut Inc, Palo Alto, CA USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
W-025
引用
收藏
页码:S101 / S101
页数:1
相关论文
共 50 条
  • [1] Population pharmacokinetic-pharmacodynamic (PK-PD) modeling of chemotherapy-induced neutropenia (CIN) in patients treated with CPX-351
    Cook, Sarah F.
    Wang, Qi
    Mager, Donald E.
    Van Wart, Scott A.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S100 - S101
  • [2] PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) MODELING OF MIDAZOLAM-FLUMAZENIL INTERACTIONS
    FISET, P
    EGAN, T
    LEMMENS, H
    SHAFER, S
    STANSKI, D
    ANESTHESIOLOGY, 1993, 79 (3A) : A362 - A362
  • [3] PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) MODELING FOR METFORMIN IN HEALTHY VOLUNTEERS.
    Kim, Y.
    Cho, S.
    Lee, D.
    Son, H.
    Roh, H.
    Son, M.
    Heo, Y.
    Park, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S48 - S48
  • [4] HYDROMORPHONE BIOAVAILABILITY AND PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) RELATIONSHIPS
    INTURRISI, C
    PORTENOY, R
    STILLMAN, M
    COLBURN, W
    FOLEY, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) : 162 - 162
  • [5] METHADONE INFUSIONS - PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) RELATIONSHIPS
    INTURRISI, C
    PORTENOY, R
    MAX, M
    COLBURN, W
    FOLEY, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 211 - 211
  • [6] Bioavailability assessment of disopyramide using pharmacokinetic-pharmacodynamic (PK-PD) modeling in the rat
    Miyazaki, M
    Maekawa, C
    Iwanaga, K
    Morimoto, K
    Kakemi, M
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (11) : 1363 - 1369
  • [7] Semi-physiological pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of 5-fluorouracil for thrombocytopenia in rats
    Kobuchi, Shinji
    Ito, Yukako
    Hayakawa, Taro
    Nishimura, Asako
    Shibata, Nobuhito
    Takada, Kanji
    Sakaeda, Toshiyuki
    XENOBIOTICA, 2015, 45 (01) : 19 - 28
  • [8] A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip
    Sung, Jong Hwan
    Kam, Carrie
    Shuler, Michael L.
    LAB ON A CHIP, 2010, 10 (04) : 446 - 455
  • [9] Incorporating Receptor Theory in Mechanism-Based Pharmacokinetic-Pharmacodynamic (PK-PD) Modeling
    Ploeger, Bart A.
    van der Graaf, Piet H.
    Danhof, Meindert
    DRUG METABOLISM AND PHARMACOKINETICS, 2009, 24 (01) : 3 - 15
  • [10] Pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of 5-fluorouracil for erythropenia in rats
    Kobuchi, Shinji
    Ito, Yukako
    Hayakawa, Taro
    Nishimura, Asako
    Shibata, Nobuhito
    Takada, Kanji
    Sakaeda, Toshiyuki
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2014, 70 (02) : 134 - 144